Acute pancretitis
Conditions
Interventions
Group A:Otreotide 25g/h, contiuously intravenous adminitration for 24h. Therapy last for 3 days. Routine therapy is the same as group B
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Inpatients aged from 18 to 65; 2. Patients with obvious upper abdominal pain and serum amylase increased 3 times more than normal maximum level with/without enlargement of pancreas or peripancreatic fluid accumulation; 3. Patients without severe disease of heart, liver, kidney, endocrine system or hematopathy; 4. Patients voluntarily signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Severe acute pancretitis and Appach II scale >8; 2. Women in pregnancy or lactation; 3. Patients have other severe disease in GI tract, such as ulcerative colitis and Clone disease; 4. Patients were complicated with liver sclerosis, esophageal varices or carcinoma; 5. Patients were wine or drug abused, psychiatric disease or any other situation that is not suitable to the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mortality;Appach II score;Somatostatin level in circulation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Average hospitalization length;Cost of treatment;Complications rate; | — |
Countries
China
Contacts
Public ContactChengwei Tang
Outcome results
None listed